OPIANT PHARMACEUTICALS, INC. (14) | Uncategorized (6)
Recent Contracts
-
Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on March 15, 2022)
-
Director Agreement, effective March 18, 2021, by and between Opiant Pharmaceuticals, Inc. and Dr. Lorianne Masuoka
(Filed With SEC on March 22, 2021)
-
Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on March 4, 2021)
-
Amendment of Solicitation/Modification of Contract
(Filed With SEC on December 14, 2020)
-
Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on March 4, 2020)
-
Open Market Sale AgreementSM, dated November 14, 2019, by and between Opiant Pharmaceuticals, Inc. and Jefferies LLC
(Filed With SEC on November 14, 2019)